Nagabhishek Moka, MD

Description

As a proud member of the ARH Care Network, I take pride in being part of a compassionate team of ARH healthcare providers that are dedicated to ensuring you have the upmost support, paramount care, and help navigating your cancer journey.

Keywords xanthogranuloma, large cell neuroendocrine tumors, solid tumors, cancer of the muscles, cancer of the joints, advanced malignancies, systemic therapy, mediastinal lymphadenopathy, human t-cell lymphotropic virus type 1, human t-cell lymphotropic virus type 2, post-chemotherapy retroperitoneal lymph node dissection, nerve-sparing retroperitoneal lymph node dissection, radical inguinal orchiectomy, testicular cancer surgery, lymph node surgery penis, salvage cryotherapy, salvage prostatectomy, androgen deprivation therapy, liquid biopsy testing, gleason score, renal cell carcinoma immunotherapy, intravesical chemotherapy, squamous cell carcinoma of penis, human papillomavirus (hpv) related penile cancer, skin cancer on penis, hereditary papillary renal cell cancer, familial renal cell carcinoma, hereditary kidney cancer, renal sarcoma, renal pelvis carcinoma, non-muscle invasive bladder cancer, muscle invasive bladder cancer, adenocarcinoma of the bladder, squamous cell carcinoma of bladder, upper tract urothelial cancer, alpha-fetoprotein tumor marker test, mesenchymal hamartoma, nut carcinoma, undifferentiated embryonal sarcoma of the liver, fibrolamellar carcinoma, ductal carcinoma in situ (dcis), lobular carcinoma in situ (lcis), prostate cancer surgery, personal history of cancer, intestinal cancer, genitourinary cancer surgery, anaplastic cancer of thyroid surgery, secondary cancer screening, long term side effects of cancer treatment, personal history of radiation therapy, personal history of chemotherapy, nasal cavity cancer chemotherapy, bladder cancer surgery, blood cancer chemotherapy, hyperthermic intraperitoneal chemotherapy (hipec), intrapleural chemotherapy, kidney cancer surgery, gynecologic cancer, cancer related cognitive disorder, blood transfusion therapy, prostate cancer chemotherapy, bladder cancer chemotherapy, testicular cancer chemotherapy, non steroidal aromatase inhibitors, hormone based chemotherapy, malignant airway tumors, adolescent and young adult cancer (aya), breast cancer biological targeted therapy, metastatic rib cancer, breast cancer immunotherapy, wilms tumor 1 mutations, relapsed hodgkin lymphoma, ovarian non germ cell tumors, lymphoproliferative disorder, denys drash syndrome (dds), autoimmune lymphoproliferative syndrome (alps), alk negative anaplastic large cell lymphoma, intravesical therapy, carcinoma of unknown primary, atypical meningioma, atypical neurofibroma, melanotic schwannoma, cancer related psychiatric disorder, cancer related anxiety disorder, cancer related depression, cancer related bereavement disorder, cancer related stress disorder, urachal tumor, squamous cell carcinoma of the head and neck, squamous cell carcinoma of the nose, squamous cell carcinoma of the tongue, melanoma of the rectum, mucosal melanoma, melanoma on toe, melanoma on foot, melanoma on trunk, melanoma on leg, thoracic cancer, aids related malignancies, intraarterial chemotherapy of tumors.